Cargando…
Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
Oxidative stress, which can cause DNA damage, can both activate TNF-R1 directly in the absence of TNF stimulation and phosphorylate c-Abl, thus promoting its cytoplasmic translocation. Persistent cytoplasmic localization of c-Abl has been associated with cellular transformation. c-Abl phosphorylates...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362849/ https://www.ncbi.nlm.nih.gov/pubmed/35958947 http://dx.doi.org/10.2147/CMAR.S373557 |
_version_ | 1784764803670081536 |
---|---|
author | Erol, Adnan |
author_facet | Erol, Adnan |
author_sort | Erol, Adnan |
collection | PubMed |
description | Oxidative stress, which can cause DNA damage, can both activate TNF-R1 directly in the absence of TNF stimulation and phosphorylate c-Abl, thus promoting its cytoplasmic translocation. Persistent cytoplasmic localization of c-Abl has been associated with cellular transformation. c-Abl phosphorylates OTULIN at tyrosine 56, thereby disrupting its relationship with LUBAC. OTULIN-released LUBAC interacts with SPATA2 and is recruited to the TNF-R1sc, facilitating SPATA2-CYLD interaction. All these interactions are required for the activation of IKKβ to stimulate NF-κB transcriptional activity following genotoxic stress. IKKβ also induces the critical phosphorylation of CYLD at serine 568 to increase its deubiquitinating (DUB) activity required for the termination of signaling cascades. Contrary to the widespread belief that CYLD is an absolute tumor suppressor, CYLD initiates and terminates NF-κB activity by alternately using its oncoprotein and tumor suppressor activities, respectively. If IKKβ fails to achieve the DUB activity-inducing phosphorylation at serine 568, CYLD would operate in a sustained mode of oncogenic activity. The resulting dysregulated NF-κB activation and other accompanying pathologies will disrupt cellular homeostasis in favor of transformation. |
format | Online Article Text |
id | pubmed-9362849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-93628492022-08-10 Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation Erol, Adnan Cancer Manag Res Perspectives Oxidative stress, which can cause DNA damage, can both activate TNF-R1 directly in the absence of TNF stimulation and phosphorylate c-Abl, thus promoting its cytoplasmic translocation. Persistent cytoplasmic localization of c-Abl has been associated with cellular transformation. c-Abl phosphorylates OTULIN at tyrosine 56, thereby disrupting its relationship with LUBAC. OTULIN-released LUBAC interacts with SPATA2 and is recruited to the TNF-R1sc, facilitating SPATA2-CYLD interaction. All these interactions are required for the activation of IKKβ to stimulate NF-κB transcriptional activity following genotoxic stress. IKKβ also induces the critical phosphorylation of CYLD at serine 568 to increase its deubiquitinating (DUB) activity required for the termination of signaling cascades. Contrary to the widespread belief that CYLD is an absolute tumor suppressor, CYLD initiates and terminates NF-κB activity by alternately using its oncoprotein and tumor suppressor activities, respectively. If IKKβ fails to achieve the DUB activity-inducing phosphorylation at serine 568, CYLD would operate in a sustained mode of oncogenic activity. The resulting dysregulated NF-κB activation and other accompanying pathologies will disrupt cellular homeostasis in favor of transformation. Dove 2022-08-05 /pmc/articles/PMC9362849/ /pubmed/35958947 http://dx.doi.org/10.2147/CMAR.S373557 Text en © 2022 Erol. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Perspectives Erol, Adnan Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation |
title | Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation |
title_full | Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation |
title_fullStr | Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation |
title_full_unstemmed | Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation |
title_short | Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation |
title_sort | genotoxicity-stimulated and cyld-driven malignant transformation |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362849/ https://www.ncbi.nlm.nih.gov/pubmed/35958947 http://dx.doi.org/10.2147/CMAR.S373557 |
work_keys_str_mv | AT eroladnan genotoxicitystimulatedandcylddrivenmalignanttransformation |